title: Quantitative determination of famotidine in human maternal plasma, umbilical cord plasma and urine using high-performance liquid chromatography-mass spectrometry.
abstract: Liquid chromatography with electrospray ionization mass spectrometry for the quantitative determination of famotidine in human urine, maternal and umbilical cord plasma was developed and validated. The plasma samples were alkalized with ammonium hydroxide and extracted twice with ethyl acetate. The extraction recovery of famotidine in maternal and umbilical cord plasma ranged from 53 to 64% and 72 to 79%, respectively. Urine samples were directly diluted with the initial mobile phase then injected into the HPLC system. Chromatographic separation of famotidine was achieved by using a Phenomenex Synergi™ Hydro-RP™ column with a gradient elution of acetonitrile and 10 mm ammonium acetate aqueous solution (pH 8.3, adjusted with ammonium hydroxide). Mass spectrometric detection of famotidine was set in the positive mode and used a selected ion monitoring method. Carbon-13-labeled famotidine was used as internal standard. The calibration curves were linear (r(2) > 0.99) in the concentration ranges of 0.631-252 ng/mL for umbilical and maternal plasma samples and 0.075-30.0 µg/mL for urine samples. The relative deviation of method was <14% for intra- and inter-day assays, and the accuracy ranged between 93 and 110%. The matrix effect of famotidine in human urine, maternal and umbilical cord plasma was less than 17%.
authors: Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, 301 University Blvd, Galveston, TX 77555-0587, USA.
authors: Xiaoming
authors: X
authors: Wang
authors: Erik
authors: E
authors: Rytting
authors: Doaa R
authors: DR
authors: Abdelrahman
authors: Tatiana N
authors: TN
authors: Nanovskaya
authors: Gary D V
authors: GD
authors: Hankins
authors: Mahmoud S
authors: MS
authors: Ahmed
mesh_terms: D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D015738:Famotidine / Q000097:blood / Q000652:urine; D005260:Female; D005312:Fetal Blood / Q000737:chemistry*; D006801:Humans; D016014:Linear Models; D013058:Mass Spectrometry / Q000379:methods*; D011247:Pregnancy; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
chemical_list: D015738:Famotidine
references: J Pharm Biomed Anal. 2005 Sep 15;39(3-4):677-80
references: 15894447
references: Gastroenterol Clin North Am. 2003 Mar;32(1):235-61
references: 12635418
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Dec 1;877(31):3953-9
references: 19853541
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jul 15;774(2):215-22
references: 12076691
references: Pharm Res. 2007 Oct;24(10):1962-73
references: 17458684
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Oct 25;825(2):186-92
references: 16213449
references: Ann Intern Med. 1993 Mar 1;118(5):366-75
references: 8257464
references: J Pharm Biomed Anal. 1998 Feb;16(6):1051-7
references: 9547709
references: J Mass Spectrom. 2001 Jul;36(7):736-41
references: 11473396
references: Am J Gastroenterol. 2009 Jun;104(6):1541-5; quiz 1540, 1546
references: 19491869
references: Best Pract Res Clin Gastroenterol. 2007;21(5):793-806
references: 17889808
references: J Pharm Biomed Anal. 2002 Nov 7;30(4):1055-61
references: 12408896
references: Gastroenterology. 1985 Apr;88(4):1026-33
references: 2857672
references: J Chromatogr B Biomed Sci Appl. 1999 Sep 10;732(1):239-43
references: 10517242
references: J Chromatogr B Biomed Sci Appl. 2001 Nov 5;763(1-2):21-33
references: 11710580